Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.

Gail MH.

J Natl Cancer Inst. 2009 Jul 1;101(13):959-63. doi: 10.1093/jnci/djp130. Epub 2009 Jun 17.

2.

Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.

Gail MH.

J Natl Cancer Inst. 2008 Jul 16;100(14):1037-41. doi: 10.1093/jnci/djn180. Epub 2008 Jul 8.

3.

Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.

McCarthy AM, Armstrong K, Handorf E, Boghossian L, Jones M, Chen J, Demeter MB, McGuire E, Conant EF, Domchek SM.

Breast Cancer Res Treat. 2013 Apr;138(3):889-98. doi: 10.1007/s10549-013-2471-8. Epub 2013 Mar 10.

4.

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.

Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA.

J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18.

5.

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.

McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K.

Breast Cancer Res. 2015 Jan 8;17:1. doi: 10.1186/s13058-014-0509-4.

6.

Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.

Dite GS, Mahmoodi M, Bickerstaffe A, Hammet F, Macinnis RJ, Tsimiklis H, Dowty JG, Apicella C, Phillips KA, Giles GG, Southey MC, Hopper JL.

Breast Cancer Res Treat. 2013 Jun;139(3):887-96. doi: 10.1007/s10549-013-2610-2. Epub 2013 Jun 18.

7.

Breast cancer risk prediction and mammography biopsy decisions: a model-based study.

Armstrong K, Handorf EA, Chen J, Bristol Demeter MN.

Am J Prev Med. 2013 Jan;44(1):15-22. doi: 10.1016/j.amepre.2012.10.002.

8.

Twenty-five years of breast cancer risk models and their applications.

Gail MH.

J Natl Cancer Inst. 2015 Feb 26;107(5). pii: djv042. doi: 10.1093/jnci/djv042. Print 2015 May. No abstract available.

9.

Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.

Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K.

Breast Cancer Res. 2012 Feb 7;14(1):R25.

10.

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.

Vachon CM, Schaid DJ, Ingle JN, Wickerham DL, Kubo M, Mushiroda T, Goetz MP, Carlson EE, Paik S, Wolmark N, Nakamura Y, Wang L, Weinshilboum R, Couch FJ.

Breast Cancer Res Treat. 2015 Jan;149(2):517-23. doi: 10.1007/s10549-014-3175-4. Epub 2015 Jan 10.

11.
12.

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.

Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB.

Breast Cancer Res. 2012 Nov 5;14(6):R144. doi: 10.1186/bcr3352.

13.

Tamoxifen and breast density in women at increased risk of breast cancer.

Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW.

J Natl Cancer Inst. 2004 Apr 21;96(8):621-8.

PMID:
15100340
14.

Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.

Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM.

J Natl Cancer Inst. 2011 May 4;103(9):744-52. doi: 10.1093/jnci/djr079. Epub 2011 Apr 11.

PMID:
21483019
15.

Projecting individualized absolute invasive breast cancer risk in African American women.

Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L.

J Natl Cancer Inst. 2007 Dec 5;99(23):1782-92. Epub 2007 Nov 27. Erratum in: J Natl Cancer Inst. 2008 Aug 6;100(15):1118. J Natl Cancer Inst. 2008 Mar 5;100(5):373.

PMID:
18042936
16.

Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography.

Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, Kontos D.

BMC Cancer. 2015 Mar 18;15:143. doi: 10.1186/s12885-015-1159-3.

17.

Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.

Atkinson C, Warren R, Bingham SA, Day NE.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):863-6.

18.

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.

Dite GS, MacInnis RJ, Bickerstaffe A, Dowty JG, Allman R, Apicella C, Milne RL, Tsimiklis H, Phillips KA, Giles GG, Terry MB, Southey MC, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):359-65. doi: 10.1158/1055-9965.EPI-15-0838. Epub 2015 Dec 16.

19.

Prospective breast cancer risk prediction model for women undergoing screening mammography.

Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.

J Natl Cancer Inst. 2006 Sep 6;98(17):1204-14.

PMID:
16954473
20.

Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.

Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith-Bindman R, Lehman C, Weaver D, Carney PA, Barlow WE.

J Natl Cancer Inst. 2010 Jul 21;102(14):1040-51. doi: 10.1093/jnci/djq233. Epub 2010 Jul 2.

Supplemental Content

Support Center